|Bid||37.39 x 100|
|Ask||46.00 x 100|
|Day's Range||43.73 - 45.76|
|52 Week Range||19.21 - 50.90|
|PE Ratio (TTM)||30.26|
|Earnings Date||Jan 22, 2018 - Jan 26, 2018|
|Forward Dividend & Yield||0.80 (1.78%)|
|1y Target Est||43.25|
Smith & Nephew's (SNN) completion of Rotation Medical acquisition appears highly strategic as this will consolidate the company's position in disruptive technologies and advance its overall growth.
Cooper Companies (COO) continues to witness impressive results at the CooperVision business segment that delivered strong sales in Q4.
Myriad Genetics (MYGN) presents positive riskScore data at the SABCS. With riskScore, the company intends to boost its myRisk Hereditary Cancer test suite.
Maxim Integrated Products (MXIM) inked a catalog distribution agreement with CoreStaff Co., Ltd. The deal will give Maxim a vast distribution network and expand its geographical presence.
Chemed (CHE) continues to display robust performance in Roto-Rooter business on strength in core plumbing and drain cleaning service segments.
Walgreens Boots' (WBA) decision to buy a minority stake in Sinopharm Holding Guoda Drugstores is likely to leverage its global pharmacy expertise.
Veeva Systems (VEEV) witnesses year-over-year growth in revenues on strength in subscription and professional services in Q3.
Rising demand for InvisAlign products in the global teen market and the distribution agreement with Patterson Dental are major upsides for Align (ALGN).
Companies like EVINE Live Inc. (EVLV), PetMed Express, Inc. (PETS) and Wal-Mart Stores Inc. (WMT) are likely to gain from the growing e-commerce market.